Article

Atractylenolide III Attenuates Muscle Wasting in Chronic Kidney Disease via the Oxidative…

Oxidative Medicine and Cellular Longevity · 2018 · Mingqing Wang, author Rong Hu, author Yanjing Wang, author Lingyu Liu, author Haiyan You, author Jiaxing Zhang, author Xiaohui Wu, author Tingting Pei, author Fujing Wang, author Lu Lu, author Wei Xiao, author Lianbo Wei, author Sara Salucci, Guest Editor

Key facts

Title Atractylenolide III Attenuates Muscle Wasting in Chronic Kidney Disease via the Oxidative Stress-Mediated PI3K/AKT/mTOR Pathway
First author Mingqing Wang, author Rong Hu, author Yanjing Wang, author Lingyu Liu, author Haiyan You, author Jiaxing Zhang, author Xiaohui Wu, author Tingting Pei, author Fujing Wang, author Lu Lu, author Wei Xiao, author Lianbo Wei, author Sara Salucci, Guest Editor
Journal Oxidative Medicine and Cellular Longevity
Published Nov 27, 2018
DOI 10.1155/2019/1875471
Devices mentioned 061454, K071580
Product codes mentioned CIT

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature